It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2018.
2018 | Hyderabad, Telangana, India | ActiveResilio Pharmaceuticals Private Limited, a active private limited company, was established on 11 July 2018 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999TG2018PTC125588. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Khaja Rahmath Ali (Director), Sudheer Kumar Bashetty (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1-5-26/2/1, Maruthi Nagar Kothapet, Hyderabad, Telangana, 500060.
U74999TG2018PTC125588
125588
11 July 2018
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Resilio Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Khaja Rahmath Ali | Director | 11 Jul 2018 | Current |
| Sudheer Kumar Bashetty | Director | 11 Jul 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Resilio Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 229.22% increase. The company also saw a substantial improvement in profitability, with a 136.19% increase in profit. The company's net worth Soared by an impressive increase of 129.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Resilio Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Resilio Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Resilio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Resilio Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Resilio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Resilio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Khaja Rahmath Ali was appointed as a Director was appointed as a Director on 11 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Sudheer Kumar Bashetty was appointed as a Director was appointed as a Director on 11 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Progress on Resilio Pharmaceuticals Private Limited was registered on 11 Jul 2018 with Roc Hyderabad & aged 7 years 4 months as per MCA records. was documented.
The CIN of Resilio Pharmaceuticals Private Limited is U74999TG2018PTC125588.
Resilio Pharmaceuticals Private Limited is headquartered at 1-5-26/2/1, Maruthi Nagar Kothapet, Hyderabad, Telangana, 500060.
Resilio Pharmaceuticals Private Limited was incorporated on 11 July 2018.
The current directors of Resilio Pharmaceuticals Private Limited are
The primary industry of Resilio Pharmaceuticals Private Limited is Trade.
Resilio Pharmaceuticals Private Limited is unlisted.
The authorized capital of Resilio Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX